Soft Tissue Sarcoma and Bone Sarcoma
Clinical research activity is centered on advanced and metastatic soft tissue sarcoma and bone tumors, including osteosarcoma, chondrosarcoma, and a broad range of small round-cell sarcomas. The portfolio also includes histologies such as leiomyosarcoma, liposarcoma, synovial sarcoma, angiosarcoma, and malignant peripheral nerve sheath tumor.
- Advanced/metastatic sarcomas
- Osteosarcoma and chondrosarcoma
- Leiomyosarcoma and liposarcoma
- Synovial sarcoma and angiosarcoma
Trial activity spans adult and young adult populations with measurable disease, reflecting a strong focus on difficult-to-treat sarcoma subtypes in the advanced setting.
Radiotherapy in Sarcoma Care
Several studies examine the use of radiotherapy alongside sarcoma-directed treatment in both localized and advanced disease. The research includes interest in palliative relief, irradiated nodules, and treatment strategies for resected or unresectable sarcoma presentations.
- Trabectedin with radiotherapy
- PM14 combined with radiotherapy
- Localized intermediate sarcoma
- Palliative response in irradiated lesions
The radiotherapy-focused work covers both soft tissue and mixed solid tumor contexts, with attention to response assessment in treated lesions.
Immunotherapy and Targeted Therapy
The sponsor supports studies involving nivolumab in combination with sunitinib and with chemotherapy backbones across several sarcoma subtypes. This includes research in undifferentiated pleomorphic sarcoma, leiomyosarcoma, alveolar soft part sarcoma, clear cell sarcoma, and related rare sarcoma cohorts.
- Nivolumab-based combinations
- Sunitinib in advanced sarcoma
- Undifferentiated pleomorphic sarcoma
- Rare sarcoma subtypes
These trials place emphasis on systemic treatment options for advanced disease, particularly in sarcoma subgroups with limited established therapeutic pathways.
Anthracycline-Based and Combination Chemotherapy
Research also covers chemotherapy combinations built around doxorubicin, ifosfamide, and dacarbazine, with an additional focus on agents paired with nivolumab or other investigational compounds. These studies involve first-line treatment settings for advanced soft tissue sarcoma.
- Doxorubicin-based regimens
- Ifosfamide combinations
- Dacarbazine combinations
- Advanced soft tissue sarcoma
The therapeutic interest includes both standard sarcoma chemotherapy platforms and newer combination approaches intended for aggressive disease.
Solid Tumors with Sarcoma Relevance
Some funded trials extend into other solid tumors, while retaining a clear sarcoma emphasis. These studies include mixed cohorts where sarcoma is assessed alongside head and neck malignancies and other advanced solid tumor types.
- Advanced solid tumors
- Head and neck cancers
- Sarcoma-inclusive cohorts
- Measurable advanced disease
The sponsor’s research landscape therefore connects sarcoma-specific development with selected broader oncology settings where treatment strategies can be evaluated across solid tumor populations.
